Aquila Bioscience’s approach is informed by an extensive review of microbiome research originating from the International Space Station.
University of Galway spin-out Aquila Biosciences and the European Space Agency (ESA) have announced a collaboration focused on ensuring safer space exploration.
As part of the project, which is sponsored by the ESA’s Discovery Programme, the research team aims to develop a nature-inspired pathogen decontamination technology for safer space exploration, as the unique conditions of spaceflight elevate the risk of infectious diseases. Traditional antimicrobial measures, while effective on Earth, are limited in space due to potential toxicity and pathogen resistance.
In an attempt to address these…